EDTA PROCEEDINGS

 

 

 

 

 

VOLUME 22

 

 

 

 

 

BRUSSELS - 1985

 

 

 

 

 

 

 

 

 

 

INTRODUCTION

 

 

 

 

 

Cover [PDF]

 

 

 

 

 

Contents [PDF]

 

 

 

 

 

Foreword [PDF]

 

 

 

 

 

Part I – STATISTICAL REPORTS

Page

 

       

Combined Report on Regular Dialysis and Transplantation in Europe,
XV, 1984
   [PDF]

3

 

 

F P Brunner, M Broyer, H Brynger, S Challah, W Fassbinder, R Oulès,

G Rizzoni, N H Selwood, A J Wing

 

 

 

 

 

 

Combined Report on Regular Dialysis and Transplantation of Children
in Europe, XIV 1984
   [PDF]

55

 

 

M Broyer, G Rizzoni, F P Brunner, H Brynger, S Challah, W Fassbinder,

R Oulès, N H Selwood, A J Wing

 

 

       

Part II – DIALYSIS I

 

 

 

 

 

 

The effect of calcium carbonate administration of nitrogen metabolism in patients on haemodialysis [PDF]

83

 

 

N J Papadoyannakis, C J Stefanidis, A Patricarea, K Kotsovasilis, A Georgiopoulou

 

 

       

Evaluation of vascular calcinosis risk factors in patients on chronic haemodialysis.
Lack of influence of the dose of calcium carbonate
[PDF]

88

 

 

H Renaud, A Atik, S Benelmoufok, M Herve, P Moriniere, Cl Galy, H Dkhissi, A Fournier

 

 

       

Effect of CaCOз supplements on serum oxalate in patients on regular
haemodialysis treatment
[PDF]

93

 

 

M Gonella, G Vagelli, S Lupetti, G Calabrese, G Pratesti

 

 

 

 

 

 

Factors influencing the hypermagnesaemia of chronic haemodialysis [PDF]

97

 

 

N Aebischer, P Aebischer, G Fellay, J P Wauters

 

 

 

 

 

 

Microcytic anaemia: a marker for the diagnosis of aluminium toxicity [PDF]

101

 

 

R D Swartz, Janet Dombrouski, Maria Burnatowska-Hledin, G H Mayor

 

 

 

 

 

 

The effect of extracorporeal haemodialysis on energy turnover [PDF]

106

 

 

H Lange, E Krautwald, G Krautwald, H Ebel

 

 

 

 

 

 

Effects of uraemia and dialysis treatment on adrenoceptor responsiveness [PDF]

111

 

 

G Fuiano, A Dal Canton, M Maj, A Testa, M G Ariano, G Conte, L Guarriello,
B Memoli, G Pacchiano, V E Andreucci

 

 

 

 

 

 

Branched chain amino acid metabolism in chronic renal failure and haemodialysis [PDF]

116

 

 

M Schreiber, S Kalhan, A McCullough, S Savin

 

 

 

 

 

 

Part   III - DIALYSIS II

 

 

 

 

 

 

Effects of long-term treatment with L-carnitine on the lipid pattern of patients
undergoing haemodialysis
[PDF]

121

 

 

G M Vacha, G Giorcelli, S D'Iddio, M Corsi

 

 

 

 

 

 

Improvement of post-dialysis glucose intolerance by dialysate carnitine
supplementation
[PDF]

127

 

 

G Panzetta, N Tessitore, E Valvo, A Lupo, C Loschiavo, L Oldrizzi, L Gammaro,
Z Bellotti, A Fabris, G Maschio

 

 

 

 

 

 

Degenerative osteo-articular lesions and amyloid infiltration in long-term
haemodialysis patients [PDF]

131

 

 

J Zingraff, T Bardin, D Kuntz, M C Voisin, J P Juquel, T Drüeke

 

 

 

 

 

 

Capsular synovial and bone amyloidosis: complications of long-term
haemodialysis
[PDF]

136

 

 

J M Vandenbroucke, J P Huaux, Th Guillaume, H Noёl, B Maldague,
C van Ypersele de Strihou

 

 

 

 

 

 

Peripheral blood mononuclear cell membrane lipid peroxidation in
haemodialysis patients
[PDF]

139

 

 

M Taccone-Gallucci, O Giardini, M Valeri, R Lubrano, D Bandino,
A Migliardi, A Piazza, V Mazzarella, G C Spagnoli, C U Casciani

 

 

 

 

 

 

Psychiatric morbidity and psychosocial adjustment after ten years of dialysis [PDF]

142

 

 

C M Le Feuvre, E A Brown, P E Gower, R Rosser

 

 

 

 

 

 

High dose vitamin C administration in harmful in patients on regular dialysis therapy [PDF]

147

 

 

P Balcke, J Zazgomik, P Schmidt, H Kopsa, A Haubenstock

 

 

 

 

 

 

Part IV - GUEST LECTURE

 

 

 

 

 

 

Convective mass transport in dialysis [PDF]

155

 

 

K M Kock, S Shaldon, C A Baldamus, M J Lysaght, G Lonnemann, M Bingel, C A Dinarello

 

 

       

Part V - GUEST LECTURE

 

 

 

 

 

 

Biocompatibility issues in haemodialysis [PDF]

163

 

 

R A Hakim

 

 

 

 

 

 

Part VI - WORKSHOP

 

 

 

 

 

 

Reuse of dialysers and blood lines [PDF]

173

 

 

P Ivanovich

 

 

 

 

 

 

Part VII - BIOCOMPATIBILITY

 

 

 

 

 

 

Hypersensitivity reactions during haemodialysis in France [PDF]

181

 

 

M Foret, F Kuentz, T Hachache, M Christollet, R Milongo, H Meftahi,
E Dechelette, D J Cordonnier

 

 

       

Cutaneous hypersensitivity reactions to dialyser extract and ethylene
oxide in haemodialysis patients [PDF]

187

 

 

C Ciancioni, C Naret, A Picot, J L Poignet, S Delons, N K Man

 

 

 

 

 

 

Interleukin-1 in hypersensitivity reactions during haemodialysis [PDF]

192

 

 

F Giacchino, M Pozzato, S Landolfo, F Quarello, A Garetto,
C Gangemi, G Giraudo, G Piccoli

 

 

       

Haemodialysis-induced acute changes in T lymphocyte subsets [PDF]

196

 

 

M Dratwa, F Collart, Francoise Mascart-Lemone, Lise de Vetter,
C Tielemans, R Wens, J Duchateau

 

 

 

 

 

 

Leucocyte elastase - a new marker of biocompatibility in haemodialysis [PDF]

202

 

 

R M Schaefer, A Heidland, W H Hörl

 

 

       

Polymorphonuclear leucocyte chemiluminescence as an index of membrane
biocompatibility [PDF]

207

 

 

L Lucchi, M A Acerbi, G Cappelli, M Leonardi, E Lusvarghi

 

 

       

Plasma granulocyte elastase during haemodialysis: effects of different dialyser
membranes and sterilization procedures [PDF]

212

 

 

W H Hörl, H B Steinhauer, W Riegel, P Schollmeyer

 

 

       

Inhibition of anaphylatoxin release by cooling the blood within the dialyser [PDF]

216

 

 

Q Maggiore, G Enia, C Catalano, V Misefari, A Mundo, G Greazzo, F Zaccuri

 

 

       

Part   VIII - WORKSHOP

 

 

 

 

 

 

Biocompatibility [PDF]

223

 

 

H Klinkmann

 

 

       

Part   IX - GUEST LECTURE

 

 

 

 

 

 

Haemodialysis hypotension: the interleukin hypothesis restated [PDF]

229

 

 

S Shaldon, G Deschodt, B Branger, C Granolleras, C A Baldamus,
K M Koch, M J Lysaght, C A Dinarello

 

 

       

Part   X - DIALYSIS COMPLICATIONS

 

 

 

 

 

 

Effect of iron overload on superoxide anion production by granulocytes
in haemodialysis patients [PDF]

247

 

 

J Flament, M Goldman, Y Waterlot, E Dupont, J Wybran, J L Wanherweghem

 

 

 

 

 

 

Platelet cyclo-oxygenase in haemodialysis patients: what suppresses its activity? [PDF]

250

 

 

H Tanaka, K Umimoto, N Izumi, T Maekawa, T Kishimoto, M Maekawa

 

 

       

Relationship between oral biotin supplementation and anaemia and dry skin
in regular haemodialysis patients [PDF]

255

 

 

K Ono, Y Hisasue, S Doi

 

 

 

 

 

 

Acute alpha- and beta-adrenoceptor regulation is impaired in hypotensive
patients on maintenance dialysis [PDF]

259

 

 

A Daul, N O'Hara, X L Wang, O-E Brodde

 

 

       

Simple test combination to localize lesions of the autonomic pathway in
hypotensive haemodialysis patients [PDF]

266

 

 

W J Brech, P Piazolo, H R Buerkle

 

 

       

Hyperchromiumaemia in chronic dialysis patients [PDF]

270

 

 

I Henderson, A Leung, D Halls, G Fell, J Dobbie, A C Kennedy

 

 

       

Trace elements binding to plasma proteins in haemodialysis [PDF]

276

 

 

M C M Mateo, A R Martin, J B Bustamante

 

 

 

 

 

 

Yersinia enterocolitica bacteraemia in haemodialysis [PDF]

283

 

 

J R Boelaert, Y J Valcke, D H Vandenbroucke, W F Lornoy,
Y Waterlot, H W Van Landuyt, J M Vandepitte

 

 

 

 

 

 

Incidence and outcome of malignancy in patients on a dialysis programme [PDF]

286

 

 

E Riambau, J Roma, E Marcuello, J Aubía, J Lloveras, J Masramón, J Torrents, E Rius

 

 

 

 

 

 

Part   XI - DIALYSIS - TECHNICAL

 

 

 

 

 

 

Percutaneous transluminal angioplasty for stenosis arteriovenous fistulas
in haemodialysed patients
[PDF]

291

 

 

G Stamatakis, F Comud, A Kanfer, F Haddoum, V Delmas, A Sibert, J Ph Méry

 

 

 

 

 

 

Assessment of arteriovenous fistulas from pressure and recirculation studies:
clinical experience in 215 upper limb fistulas
[PDF]

296

 

 

R N Greenwood, C Aldridge, L Goldstein, L R I Baker, W R Cattell

 

 

 

 

 

 

Long-term experience with hypertonic haemodiafiltration [PDF]

303

 

 

C Basile, A DiMaggio, A Scatizzi

 

 

 

 

 

 

Small and middle molecule removal in hypertonic haemodiafiltration [PDF]

308

 

 

C Basile, A DiMaggio, A Scatizzi

 

 

 

 

 

 

Haemodialysis: only six hours once a week [PDF]

312

 

 

E Rotellar, M E Martinez, A Plans, A Ferragut

 

 

 

 

 

 

Acute changes in plasma free fatty-acid concentration during haemodialysis
comparing heparin with epoprostenol as anticoagulant
[PDF]

321

 

  S J Davies, S M Hobson, G A Young, J H Turney    

 

 

 

 

Local experience of regional anticoagulation with sodium citrate for haemodialysis
in patients at risk of bleeding
[PDF]

325

 

 

F Collart, C Tielemans, R Wens, M Dratwa

 

 

 

 

 

 

Preliminary evaluation of repeated use of a low molecular weight heparin
in haemodialysis for chronic renal failure
[PDF]

329

 

 

E G Anastassiades, D A Lane, A Flynn, J R Curtis

 

 

     

The usefulness of the multi-enzyme inhibitor, nafamstat mesilate, in high
bleeding risk haemodialysis
[PDF]

334

 

 

T Akizawa, M Sato, T Kitaoka, S Koshikawa, Y Asano,Y Hirasawa, K Iida,
N Mimura, K Nakamura, M Kazama, K Ota

 

 

     

PART XII – WORKSHOP

 

 

 

 

 

 

Single needle dialysis [PDF]

341

 

 

N A Hoenich

 

 

 

 

 

 

PART XIII – ALUMINIUM

 

 

 

 

 

 

Aluminium concentrations in plasma, bone and hair in patients on long-term
haemodialysis
[PDF]

349

 

 

B Winterberg, H P Bertram, S Remmers, J Remmers, A E Lison, H Losse, H Zumkley

 

 

 

 

 

 

Spinal fluid aluminium in haemodialysed uraemic patients [PDF]

354

 

 

D Brancaccio, O Bugiani, L Pacini, A Berlin, J Bisceglia, M Gallieni,
M Surian, S Costantini, R Giordano, M Rizzica

 

 

 

 

 

 

Link between HLA-B40 and dialysis encephalopathy [PDF]

360

 

 

P Garret, Susan Spencer, D Mulcahy, P Hanly, J A O'Hare, D J Murnaghan,
J S Hanson, J F Donohoe, M Carmody, W F O'Dwyer

 

 

 

 

 

 

Renal osteodystrophy in chronic haemofiltration and haemodialysis:
a comparative histological study at comparable mild aluminium
overload induced by Al(OH)з
[PDF]

363

 

 

P Fohrer, J F de Fremont, Ph Moriniere, C Galy P Leflon, G Lambrey,
B Boudailliez, H Renaud, A Atik,
J L Sebert, A Fournier

 

 

       

Aluminium containing oral phosphorus binders and the aluminium content of bone [PDF]

369

 

 

H Raidt, M Vischedyck, H Kellinghaus, D Steinhausen, U Graefe

 

 

 

 

 

 

Impaired transport of the iron-transferrin complex and microcytic anaemia in
haemodialysis
patients with aluminium intoxication
[PDF]

374

 

 

P Simon, K S Ang, G Cam

 

 

       

Is unresponsiveness of aluminium-induced osteomalacia due to
cellular 1,25(OH)
Dз resistance? [PDF]

382

 

 

J Merke, F Hellbing, E Ritz

 

 

 

 

 

 

Comparison of aluminium removal on an AN69-S membrane and a charcoal filter [PDF]

386

 

 

R M Valentijn, P Batavier, I M Schicht

 

 

 

 

 

 

Does desferrioxamine induce aluminium load in patients on chronic haemodialysis? [PDF]

388

 

 

K Wagner, T Lenz, F Keller, H H Neumayer, R Fitzner, U Pipenhagen, H J Dulce,
A Distler, M Molzahn

 

 

 

 

 

 

PART XIV – CONTINUOUS AMBULATORY PERITONEAL DIALYSIS

 

 

 

 

 

 

Prophylaxis against Staphylococcus aureus peritonitis in continuous ambulatory
peritoneal dialysis
[PDF]

392

 

 

A Scatizzi, P Strippoli

 

 

 

 

 

 

The high morbidity of fungal peritonitis in continuous ambulatory peritoneal dialysis [PDF]

397

 

 

W G J Smith, D Tsakiris, J D Briggs, B J R Junor

 

 

 

 

 

 

Risk factors for peritonitis and technique failure in CAPD: increased age and
dialysate IgG protect against peritonitis
[PDF]

401

 

 

D N Bennett-Jones, A Eaton, J S Cameron, C S Ogg, D G Williams

 

 

 

 

 

 

Permeability of the peritoneum to proteins in continuous ambulatory peritoneal
dialysis patients with systemic disease
[PDF]

405

 

 

R T Krediet, E W Boeschoten, F M J Zuyderhoudt, L Arisz

 

 

 

 

 

 

Trace element abnormalities in continuous ambulatory peritoneal dialysis [PDF]

410

 

 

A Leung, I Henderson, D Halls, G Fell, A C Kennedy

 

 

 

 

 

 

The advantage of glucose polymer as an osmotic agent in continuous
peritoneal dialysis [PDF]

415

 

 

C D Mistry, N P Mallick, R Gokal

 

 

 

 

 

 

Use of amino acid containing solutions in continuous ambulatory peritoneal dialysis
patients after peritonitis: results of a prospective controlled trial
[PDF]

421

 

 

H Schilling, G Wu, J Pettit, A Mitwalli, H G Anderson, R Ogilvie, D G Oreopoulos

 

 

 

 

 

 

Clinical experience with short peritoneal catheters [PDF]

426

 

 

S Chiaramonte, M Feriani, S Biasoli, L Bragantini, A Brendolan, R Dell'Aquila,
A Fabris, C Ronco, G La Greca

 

 

 

 

 

 

Complications post renal transplantation in children on continuous
ambulatory peritoneal dialysis/continuous cycling peritoneal dialysis:
a comparison to haemodialysis
[PDF]

431

 

 

H E Leichter, R B Ettenger, I B Salusky, T von Lilien, S C Jordan,
T Hall, J Marik, R N Fine

 

 

 

 

 

 

PART XV – GUEST LECTURE

 

 

 

 

 

 

Pregnancy in women with renal disease and renal transplantation [PDF]

439

 

 

J M Davison, A I Katz, M D Lindheimer

 

 

       

PART XVI – GUEST LECTURE

 

 

 

 

 

 

Renal haemodynamics and salt balance in pregnancy [PDF]

463

 

 

A Dal Canton, V E Andreucci

 

 

       
PART XVII – PREGNANCY    
       

The effect of pregnancy on the natural history of primary glomerulonephritis [PDF]

473

 

 

P Barcelo, J L Lopez-Lillo, J A Ballarín, G del Rio

 

 

       

The effects of pregnancy on amyloid nephropathy in familial mediterranean fever [PDF]

478

 

 

S Cabili, O Rabinovitch, D Zemer, A Aviram, M Pras

 

 

       

IgA nephropathy and pregnancy [PDF]

482

 

 

P Jungers, D Forget, D Droz, L H Noel, M Henry-Amar

 

 

       

The outcome of pregnancy in patients with lupus nephritis [PDF]

487

 

 

J S Cameron, J Hicks, G Frampton, D G Williams, C S Ogg

 

 

       

Exaggerated natriuresis in chronic hypertension in pregnancy [PDF]

493

 

 

G Conte, A Dal Canton, M Terribile, G Fuiano, C Esposito, V Andreucci

 

 

       

Abnormal renal function in hypertensive pregnant women: reversal
by left lateral decubitus [PDF]

498

 

 

M Labeeuw, N Pozet, A Hadj Aissa, M Vincent, P Zech

 

 

       

Improvement of renal function during pregnancy in patients with
a cadaveric renal allograft [PDF]

503

 

 

A M Tegzess, S Meijer, G H A Visser, W J van Son, F J van der Woude, W J Sluiter

 

 

       

Pregnancy after renal transplantation: are graft and fetus risks predictable? [PDF]

508

 

 

Y Pirson, M Van Lierde, J Ghysen, J P Squifflet, G P J Alexandre,
C van Ypsersele de Strihou

 

 

       
PART XVIII – WORKSHOP    
       

The kidney and pregnancy [PDF]

515

 

 

M Beaufils

 

 

       

PART XIX – GUEST LECTURE

   
       

Kidney and pancreas transplantation in man: the current position [PDF]

521

 

P McMaster, W A Jurewicz, B K Gunson, L Angrisani, R M Kirby

 

 

       

PART XX – CYCLOSPORIN A IN TRANSPLANTATION

 

 

       

Nephrotoxicity and pharmacokinetics of Cyclosporin A in renal transplant recipients [PDF]

535

 

 

F C Henny, C H Kleinbloesem, A J Moolenaar, L C Paul, D D Breimer, L A van Es

 

 

       

Cyclosporin A nephrotoxicity: comparison of biopsy histological findings in renal
transplant patients treated with Cyclosporin A or azathioprine [PDF]

540

 

 

S Kabalan, F E Dische, G H Neild, M Bewick, V Parsons

 

 

       

Are Cyclosporin A deposits in renal allografts of clinical significance? [PDF]

546

 

 

P Scaini, R Tardanico, M Favret, F Scolari, S Savoldi, G C Cancarini,
E Prati, S Sandrini, G Brunori, L Cristinelli

 

 

       

Renal function and blood pressure in heart transplant recipients treated
with Cyclosporin A [PDF]

551

 

 

J Rottembourg, M F Mattei, A Cabrol, P Leger, B Aupetit, H Beaufils,
J C Gluckman, A Pavie, I Gandjbakhch, C Cabrol

 

 

       

Inhibition of renal gluconeogenesis by Cyclosporin A in rats [PDF]

556

 

 

W Beck, K Schärer, R Waldherr, F Trefz, H Schmidt-Gayk

 

 

       

Cyclosporin A and urine glutathione-S-transferase [PDF]

561

 

 

D A Feinfeld, A Benvenistry, V D'Agati, M A Hardy

 

 

       

Factor VIII-related antigen levels in renal allograft recipients taking Cyclosporin A [PDF]

566

 

 

Z Brown, G H Neild, J J Willoughby, N V Somia, J S Cameron

 

 

       

Cyclosporin A or azathioprine combinated with prednisone in renal allotransplantation
with convension from Cyclosporin A to azathioprine at four months [PDF]

571

 

 

C P Ramos

 

 

       

PART XXI – WORKSHOP

   
       

Cyclosporin A in clinical practice [PDF]

579

 

 

G Thiel

 

 

       

PART XXII – GUEST LECTURE

   
       

Immunological factors influencing renal allograft survival [PDF]

585

 

 

G Opelz

 

 

       

PART XXIII – CLINICAL TRANSPANTATION I

   
       

99mTc Sn colloid scans in the diagnosis of renal graft rejection [PDF]

605

 

 

F X Sundram, R P S Edmondson, E S Ang

 

 

       

Magnetic resonance imaging in renal transplants [PDF]

609

 

 

L J Schultze Kool, L te Strake, L C Paul, A M Tegzess, J L Bloem,
J Doornbos, R G Bluemm

 

 

       

Identification of a hitherto undescribed Leu-7/Leu-3 lymphocyte subset
in long-term renal allotransplant recipients [PDF]

614

 

 

Ch M Legendre, R D Guttmann

 

 

       

Human retroplacental gamma globulin: past experience and proposed use
with low dose Cyclosporin A in cadaveric kidney transplantation [PDF]

619

 

 

R R Riggio, R Haschemeyer, J Cheigh, M Suthanthiran, L Tapia,
W Stubenbord, K H Stenzel

 

 

       

Study of pre-sensitization by flow cytometry in cadaveric kidney recipients [PDF]

622

 

 

C Stabile, J P Bernhardt, B W Colombe, K Huebner, D Wood, V Lim,
W Amend, F Vincenti, J Melzer, N Feduska, O Salvatierra, M R Garovoy

 

 

       

Expression of HLA-DR antigen on endothelial cells in kidney allografs [PDF]

627

 

 

G Leimenstoll, M Stitz, P Zabel, E Deltz, W Niedermayer

 

 

       

Cytomegalovirus infections after renal transplantation: effect of prophylactic
hyperimmunoglobulin
[PDF]

630

 

 

E-H Scheuermann, P-B Bechstein, W Schoeppe, W Fassbinder

 

 

       
PART XXIV – CLINICAL TRANSPLANTATION II    
       

The selection of donors for highly sensitized patients [PDF]

635

 

 

P T Klouda, B A Bradley, T C Ray, N H Selwood

 

 

       

Dissecting the centre effect [PDF]

639

 

 

B A Bradley

 

 

       

Cytomegalovirus retinitis in a renal transplant patient with recurrent opportunist
infection: treatment with foscarnet and CMV hyperimmune globulin [PDF]

645

 

 

D R J Singer, T J Fallon, W E Schulenburg, A S Boyd, J Cohen, G Williams

 

 

       

Erythrocytosis after kidney allotransplantation: haematological characterisation
and complications [PDF]

651

 

 

G Keusch, H Jungbluth, K Mühlethaler, J Fehr, U Binswanger

 

 

       

IgM immune complexes, leucocytotoxins and rheumatoid factors during active
cytomegalovirus infections in renal graft recipients treated with azathiopine,
Cyclosporin A or anti-thymocyte globulin
[PDF]

655

 

 

W M Baldwin III, F C Henny, F H J Claas, G W van Gemert, M L Westedt,
L C Paul, M R Daha, J J Haaijman, J Radl, L A van Es

 

 

       

Risk factors associated with aseptic bone necrosis following renal transplantation [PDF]

660

 

 

D Tsakiris, T C Aitchison, J D Briggs, J K Davidson, B J R Junor

 

 

       

Serum neopterin after kidney transplantation - a useful tool for graft monitoring? [PDF]

665

 

 

E Pohanka, M Schwarz, G Mayer, W Woloszczuk, J Kovarik, H K Stummvoll

 

 

       

Neopterin in urine and serum after kidney transplantation [PDF]

672

 

 

C Noel, J L Dhondt, M Dracon, G Lelievre, A Tacquet

 

 

       

Rescue of steroid-resistant rejections with OKT3.PAN [PDF]

677

 

 

E Rivolta, A De Vecchi, A Tarantino, F M Egidi, A Vegato, C Ponticelli

 

 

       
PART XXV – GUEST LECTURE    
       

Toxic immune glomerulopathy [PDF]

683

 

 

P Druet

 

 

       
PART XXVI – GLOMERULAR DISEASE    
       

Plasma exchange in lupus nephritis [PDF]

699

 

 

S J Haworth, C D Pusey, C M Lockwood

 

 

       

Anti-bovine serum albumin antibody idiotypes in patients with IgA nephropathy [PDF]

705

 

 

J Gonzalez-Cabrero, J Egido, J Sancho, F Moldenhauer, L Hernando

 

 

       

May gluten-free diet reduce the levels of IgA immune complexes in primary IgA
nephropathy? [PDF]

710

 

 

R Coppo, B Basolo, C Rollino, D Roccatello, G Martina, A Amore, G Bongiorno, G Piccoli

 

 

       

Factors affecting the progression of IgA nephritis [PDF]

715

 

 

K T Woo, R P S Edmondson, A Y T Wu, G S C Chiang, H S Pwee, C H Lim

 

 

       

Immunosuppressive treatment of 34 patients with microscopic polyarteritis [PDF]

720

 

 

C O Savage, C G Winearls, D J Evans, A J Rees, C M Lockwood

 

 

       

End-stage renal failure associated with occupational exposure to organic solvents [PDF]

725

 

 

G M Bell, A Doig, D Thomson, J L Anderton, J S Robson

 

 

       

Reduction in the incidence of membranoproliferative glomerulonephritis in France [PDF]

730

 

 

P Jungers, D Forget, D Droz, L H Noel, J P Grunfeld

 

 

       
PART XXVII – IMMUNOPATHOLOGY    
       

Specific immunoabsorption in a rat model of Goodpasture's syndrome [PDF]

736

 

 

C D Pursey, C J Ryan, M Aslam, J-J Lloveras, A J Dileo, C M Lockwood

 

 

       

Abnormal expression of the Goodpasture antigen in patients with Alport's syndrome [PDF]

742

 

 

C O S Savage, C D Pusey, M Kershaw, S Cashman, P Harrison, B Hartley,
D R Turner, J S Cameron, D J Evans, C M Lockwood

 

 

       

Characterization of target antigens in Goodpasture's syndrome [PDF]

746

 

 

M Weber, H Köhler, M Manns, P Kurz, K-H Meyer zum Büschenfelde

 

 

       

T lymphocyte and macrophage involvement in the glomerular lesions
of microscopic polyarteritis
[PDF]

752

 

 

F Nolasco, J S Cameron, B Hartley

 

 

       

Defective function with normal expression of cell-surface Fc receptors
in mixed cryoglobulinaemia
[PDF]

759

 

 

D Roccatello, R Coppo, G Martina, F Malavasi, A Funaro, B Basolo,
E Bancale, C Rollino, A Amore, G Piccoli

 

 

       

Demonstration of Cзd and Cзь in mesangial IgA-glomerulonephritis and
Henoch-Schönlein purpura nephritis [PDF]

763

 

 

E W Rauterberg, Anne-Margaret Wingen, H-M Lieberknecht, E Ritz

 

 

       

Inherited variations in glomerular properties [PDF]

767

 

 

J M Boulton-Jones, L Chandrachud

 

 

       

Immunochemical characterization of cationic IgG in patients with membranous
nephropathy and declining renal function
[PDF]

773

 

 

P E C Brenchley, B M Coupes, C D Short, M P Mallick

 

 

       
PART XXVIII – IMMUNOLOGY - IMMUNOPATHOLOGY    
       

Renal involvement due to heroin addiction [PDF]

778

 

 

J M López-Gómez, M G Vinuesa, V Barrio, E Niembro, T Grau, J Solares,
A Alvarez, A Franco, F Valderrabano

 

 

       

Absence of IgA in the glomerular deposits of patients with cirrhosis
of the liver and glomerulopathy [PDF]

784

 

 

J Montoliu, A Darnell, A Torras, X M Lens, L Revert

 

 

       

Urinary complement breakdown product, Cзd,g, in membranous nephropathy
- a marker of disease activity? [PDF]

790

 

 

B M Cupes, C D Short, P E C Brenchley, S Boyd, N P Mallick

 

 

       

Intradermal skin testing in the loin pain haematuria syndrome [PDF]

796

 

 

G M Bell, D Thomson, J L Anderton, A T Lambie, A Doig

 

 

       

Tonsillectomy decreases the synthesis of polymeric IgA by blood lymphocytes
and clinical activity in patients with IgA nephropathy
[PDF]

800

 

 

L Lozano, R Garcia-Hoyo, J Egido, R Blasco, J Sancho, L Hernando

 

 

       

The regulation of the autoimmune response in active Heymann's nephritis
by T cell subsets in Lewis rats
[PDF]

805

 

 

E de Heer, M R Daha, L A van Es

 

 

       

Effect on lymphocyte function of transfusion-related serum factors [PDF]

809

 

 

M A Forwell, J E Cocker, M G Peel, J D Briggs, B J R Junor,
R N M MacSween, G P Sandilands

 

 

       

Abnormal immune response in patients with minimal change nephropathy
in remission
[PDF]

813

 

 

A H Wilkinson, D G Williams

 

 

       
PART XXIV – WORKSHOP    
       

Immunopathology of nephritis [PDF]

819

 

 

Ph J Hoedemaeker

 

 

       
PART XXX – GUEST LECTURE    
       

Pathophysiology and management of hypertension during pregnancy [PDF]

823

 

 

M D Lindheimer, J M Davison, A I Katz

 

 

       
PART XXXI – HYPERTENSION-PHYSIOLOGY    
       

Diet and blood glucose: effects on renal response to acute dietary protein
challenge in diabetics with elevated glomerular filtration rate
[PDF]

843

 

 

G C Viberti, E Bognetti, M J Wiseman

 

 

       

Extracellular volume and blood pressure in 82 haemodialysed children [PDF]

847

 

 

D Leroy, M Dechaux, G Guest, M Broyer, C Sachs

 

 

       

Plasma renin activity circadian rhythm in hypertensive subjects [PDF]

851

 

 

G del Rosso, B Di Paolo, D Viola, F Capani, A Consoli, A Albertazzi

 

 

       

Influence of angiotensin II and catecholamines on prostanoid synthesis
by isolated rat glomeruli
[PDF]

858

 

 

E Podjarny, H Magen, M Rathaus, J Bernheim

 

 

       

NADH-dependent PGE₂-9-ketoreductase activity in the kidney of diabetes insipidus
Brattleboro and Long Evans rats: relationship with urinary PGE₂ and PGF₂α excretion
[PDF]

862

 

 

M Rathaus, M Werber, N Kariv, E Podjarny, J Bernheim

 

 

       

Effects of thyroid hormones on sodium diffusion across proximal tubular brush
border membranes
[PDF]

865

 

 

F Turrini, B Contu, T De Nurra, A Ginanni, A Satta, M Branca, E Bartoli

 

 

       

The effect of angiotensin II on kidney function [PDF]

871

 

 

J Shohat, G Boner, J Rosenfeld

 

 

       
PART XXXII – CARDIOVASCULAR    
       

Malignant essential hypertension: comparison with malignant hypertention in
IgA nephropathy
[PDF]

875

 

 

X M Lens, J Montoliu, R Subias, A Botey, A Darnell, L Revert

 

 

       

High incidence of proximal renal artery lesions in accelerated or malignant hypertension [PDF]

880

 

 

C Guérin, C Genin, R Gontheir, J C Sabatier, J Toulon, G Leroy, X Barral,
C Veyret, F C Berthoux

 

 

       

Interaction between dietary sodium and calcium in blood pressure control in
essential hypertention [PDF]

884

 

 

C Zoccali, D Iellamo, S Parlongo, Q Maggiore

 

 

       

Kinetics of Nifedipine in patients treated with maintenance haemodialysis [PDF]

889

 

 

H Martre, C Jacobs, E Singlas, R Sari, A M Taburet

 

 

       

Decreased urinary kallikrein excretion prior to delivery in pregnancy induced hypertention [PDF]

894

 

 

R Sipilä, M Jalkanen, K Huotari

 

 

       

Salt preference in pregnant hypertensive rats [PDF]

898

 

 

M Sabbatini, M Altomonte, G Conte, C Esposito, G Romano,
F Uccello, P Veniero, V E Andreucci, A Dal Canton

 

 

       

Myocardial beta adrenergic receptor response coupling in rats with chronic renal failure [PDF]

901

 

 

K Kumano, S Yokota, T Sakai

 

 

       

Characterization of uraemic cardiomyopathy by left heart catheterization with
serial analysis of pressure-volume relations and myocardial O
₂ consumption [PDF]

906

 

 

V Wizemann, W Kramer, J Thormann, M Kindler

 

 

       

Cardiovascular complications in patients with adult polycystic kidney disease [PDF]

910

 

 

R Götz, K Schafferhans, R M Schaefer, P Schanzenbächer, M Teschner,
E Heidbreder, A Heidland

 

 

       
PART XXXIII – URAEMIA    
       

Glucagon-mediated modifications of glomerular filtration rate induced by
essential aminoacids and ketoanalogues [PDF]

917

 

 

P Cappelli, G Del Rosso, B di Paolo, M Egangelista, M T Nisi, A Albertazzi

 

 

       

The effect of dietary protein quality in experimental renal disease [PDF]

921

 

 

A J Williams, F E Baker, J Walls

 

 

       

Low protein diet prevents glomerular damage in adriamycin-treated rats [PDF]

927

 

 

G Remuzzi, C Zoja, A Remuzzi, M Rossini, C Battaglia, M Broggini, T Bertani

 

 

       

Restoration of uraemic lymphocyte responses in vitro by interleukin-2 [PDF]

932

 

 

E Langhoff, J Ladefoged, K Olgaard, S Madsen

 

 

       

Importance of the role of the blood transfusions in delayed hypersensivity
among end-stage renal disease patients
[PDF]

937

 

 

F Louis, P Ruedin, D Frei, M Jeannet, H Favre

 

 

       

Immune defects in the early stage of chronic renal failure [PDF]

941

 

 

P Kurz, H Köhler, T Hüteroth, M Weber, K H Meyer zum Büschenfelde

 

 

       

Platelet function is enhanced, not depressed in uraemia [PDF]

946

 

 

P B Rylance, M P Gordge, M J Weston

 

 

       

How to evaluate the carbohydrate intolerance in uraemia. Is serum reverse
Tз clinically useful?
[PDF]

953

 

 

S De Marchi, E Cecchin, G Panarello, F Testio

 

 

       
PART XXXIV – GUEST LECTURE    
       

Prevention of aminoglycoside nephrotoxicity [PDF]

959

 

 

M E De Broe

 

 

       
PART XXXV – GUEST LECTURE    
       

Analgesic nephropathy [PDF]

977

 

 

U C Dubach

 

 

       
PART XXXVI – WORKSHOP    
       

Analgesic nephropathy [PDF]

987

 

 

U C Dubach

 

 

       
PART XXXVII – NEPHROTOXICITY - AMINOGLYCOSIDES    
       

Mefenamic acid nephropathy - a spectrum of renal lesions [PDF]

991

 

 

A J Nicholls, J R Shortland, C B Brown

 

 

       

Analgesic nephropathy and aluminium toxicity [PDF]

997

 

 

A Schwarz, D Kraft, F Keller, W Meyer-Sabellek, D Gawlik, G Offermann

 

 

       

Drug-associated acute renal failure. A prospective multicentre report [PDF]

1002

 

 

D Kleinknecht, P Landais, B Goldfarb

 

 

       

Cortex and medullary proton magnetic resonance in gentamicin and glycerol
acute renal failure in rats
[PDF]

1008

 

 

A Iaina, S Abrashkin, J Weininger, L Grifel, R Shneider, M Gross, L Lupo, H Rosenman

 

 

       

Prevention of glycerol-induced acute renal failure in rabbits by the
thromboxane-antagonist BM 13.505
[PDF]

1012

 

 

K Stegmeier, F Hartig, J Pill, H Patscheke

 

 

       

Neonatal diabetes insipidus due to maternal lithium therapy during pregnancy [PDF]

1017

 

 

M Van Dyke, R Van Damme-Lombaerts, W Proesmans

 

 

       

Mitomycin-induced renal injury [PDF]

1020

 

 

V Cattell

 

 

       

Nephrotoxicity of high dose methotrexate therapy - a long-term follow-up study
in five juvenile patients with osteosarcoma
[PDF]

1025

 

 

R Wartha, M Damjantschitsch, V Damjanschitsch, J Kuehl, D Gekle

 

 

       
PART XXXVIII – WORKSHOP    
       

Toxic acute renal failure [PDF]

1033

 

 

J P Grünfeld

 

 

       
PART XXXIX – PROSTAGLANDINS/HORMONES    
       

The effect of Felodipine a new calcium antagonist on renal function [PDF]

1037

 

 

D A S Jenkins, K J Craig, A M Macnicol, M L Watson

 

 

       

Urinary PGE₂ and PGF₂α in diabetes insipidus Brattleboro and Long Evans rats
submitted to potassium loading [PDF]

1042

 

 

M Rathaus, N Kariv, J Shapira, E Podjarny, J Bernheim

 

 

       

Role of endogenous prostaglandins on the release of anti diuretic hormone [PDF]

1045

 

 

M Usberti, G DiMinno, B Ungaro, A Gargiulo, F Martucci, G Ardillo,
B Cianciaruso, V Calderaro, S Federico

 

 

       

Increase of glomerular filtration rate following aminoacid infusion is suppressed
by indomethacin in normal subjects
[PDF]

1049

 

 

T Eisenhauer, K Scholz, F Scheler

 

 

       

Effect of an acute sodium chloride load on the urinary excretion of prostaglandins
E
and F₂ in antidiuretic suppressed dogs [PDF]

1054

 

 

M Schneider, I Erez, B Shpitz, M Rathaus, J Bernheim

 

 

       

Kallikrein-kinin system involvement in chronic glomerular disease [PDF]

1057

 

 

A Pierucci, B M Simonetti, F Pugliese, M Manzi, P Mené, G Stirati, G A Cinotti

 

 

       

Diurnal pattern of serum cortisol and adrenal cortisol reserve in patients with
nephrotic syndrome
[PDF]

1062

 

 

S Czekalski, K Napierala, W Wielczko, J Lapis, S Pynka

 

 

       

Pancreatic beta cell function in non diabetic patients with renal failure [PDF]

1067

 

 

W G J Smith, I Hanning, D G Johnston, A T Raftery, C B Brown

 

 

       
PART XL – CLINICAL NEPHROLOGY I    
       

Hepatitis B vaccine in non-dialysed uraemic patients: preliminary results [PDF]

1073

 

 

P Jungers, Ph Chauveau, A M Couroucé, B Mattlinger, J Crosnier

 

 

       

Improvement of immune response in dialysis patients to Hevac B vaccine
after multiple injections of vaccine [PDF]

1077

 

 

P Michel, G Janin, S El Yafi, P Chevallier, P Girard, M Laville, C Trepo

 

 

       

Low-protein diet increases serum albumin by reducing proteinuria in some
nephrotic patients [PDF]

1083

 

 

J van der Meulen, L Gooren, P L Oe

 

 

       

Monitoring renal toxicity of cis-platinum by urinary enzymes [PDF]

1087

 

 

U Metz, E Kurschel, N Graben

 

 

       

Rhabdomyolysis and myoglobinuria in 19 patients with chronic alcoholism [PDF]

1091

 

 

K W Rumpf, T H Henz, H Kaiser, H Klein, H Prange, F Scheler

 

 

       

The effect of preventive administration of nifedipine on acute ischaemic renal
failure in hydropenic dogs
[PDF]

1096

 

 

T Natsheh, E Alexopoulos, A Dimitriadis, T Tsobanelis, S Kalpakoglou, M Papadimitriou

 

 

       

Characterization of neutral proteinases in urine from nephrotic rats with a
proliferactive or a non-proliferactive glomerular disease
[PDF]

1103

 

 

J C Davin, M Davies, J M Foidart, J B Foidart, C A Dechenne, P R Mahieu

 

 

       

Morphine transport in the isolated perfused rat kidney [PDF]

1109

 

 

P J Radcliffe, J W Sear, C W Hand, R A Moore

 

 

       
PART XLI – CLINICAL NEPHROLOGY II    
       

Influence of a meat-free diet on the urinary excretion of 3-methylhistidine
and creatinine in chronic renal failure [PDF]

1115

 

 

A Gutierrez, G A Qureshi, J Bergström

 

 

       

Sites of defective regulation of prolactin secretion in chronic renal failure [PDF]

1119

 

 

B Cianciaruso, A Capuano, M Iodice, A Auciello, R Iandolo, D Bonanno,
F Marcuccio, V E Andreucci

 

 

       

Reduced 1,25 (OH)₂ Dз may be responsible for the development of
hyperpatathyroidism in early chronic renal failure [PDF]

1124

 

 

P A Luca, R C Brown, C R Jones, J S Woodhead, G A Coles

 

 

       

Abnormal lipoprotein metabolism in incipient renal failure [PDF]

1129

 

 

A Gnasso, W Haberbosch, J Augustin, E Ritz

 

 

       

Selenium deficiency in chronic uraemia and dialysis [PDF]

1134

 

 

A Leung, I Henderson, G Fell, D Hall, A C Kennedy

 

 

       

A study of factors responsible for the low concentration of α-tocopherol in
chronic renal failure [PDF]

1139

 

 

S Yukawa, K Mori, H Nomoto, N Nishikawa, I Nishide

 

 

       

Human cytomegalovirus in the urine of patients with chronic renal failure [PDF]

1145

 

 

K Gmelin, L Theilmann, B Widenmann, P Klooker, M Rambausek, K Dreikorn,
J Bommer, M Renz, R Braun, B Kommerell, E Ritz

 

 

       

Correlation between serum phosphate concentration and rate of progression
of chronic renal failure
[PDF]

1148

 

 

N Gretz, E Meisinger, M Strauch

 

 

     

 

Progression of chronic renal failure is retarded with more frequent clinical follow-up [PDF]

1153

 

 

J Bergström, A Alvestrand, H Bucht, A Gutierrez

 

 

     

 

PART XLII – CLINICAL NEPHROLOGY III    
       

The therapeutic advantage of soft versus hard water in calcium stone-formers treated
with hydrochlorothiazide is dependent upon concomitant oxalate restriction [PDF]

1159

 

 

P Bataille, M Finez, H Renaud, P Leflon, P Rogez, B Tribout, P Fievet, A Fournier

 

 

       

Transient hyperoxaluria after ingestion of food rich in oxalic acid as a high-risk
factor for calcium oxalate calculi
[PDF]

1163

 

 

P Balcke, J Zazgornik, G Sunder-Plassmann, H Kopsa, F Gremmel, K Derfler, A Kiss

 

 

       

Comparison of motor nerve conduction velocity and vibratory perception as long
term markers of uraemic polyneuropathy
[PDF]

1167

 

 

H Raidt, R Hachmöller, D Steinhausen, U Graefe

 

 

       

The role of alpha-1-microglobulin in the evaluation of tubular impairment and as a
parameter superior to creatinine in the estimation of glomerular filtration rate
[PDF]

1173

 

 

M H Weber, P Scholz, F Scheler

 

 

       

99 m Tc-Aprotinin uptake test and separate kidney function [PDF]

1178

 

 

C Aprile, R Saponaro, G Villa, M Carena, A Salvadeo, F Lunghi, V Piazza, E Petrella

 

 

       

¹¹¹Indium-oxine labelled platelets in the diagnosis of renal allograft rejection
during Cyclosporin A therapy
[PDF]

1183

 

 

J M Griño, J Torras, J Martin-Comin, J Mora, I Sabate, A M Castelao, M Roca, J Alsina

 

 

     

 

Treatment of acute renal failure in the newborn by continuous arteriovenous
haemofiltration
[PDF]

1187

 

 

C Ronco, A Brendolan, L Bragantini, S Chiaramonte, A Fabris, M Feriani,
L Menicanti, A Saccaggi, G La Greca

 

 

     

 

Acute renal failure in children [PDF]

1193

 

 

M Rengel, J Fernandez-Llebrez, L Garcia, F Vargas-Zuniga, P Caro, M Desco, F Gómez

 

 

     

 

Semi-controlled multicentre study of double filtration plasmapheresis in systemic
lupus erythematosus
[PDF]

1200

 

 

T Agishi, T Takuma, H Amemiya, K Ito, H Kawaguchi, H Hashimoto, J Yamagata,
N Koga, Y Yamagata

 

 

     

 

PART XLIII – CALCIUM - VITAMIN D - PARATHYROID HORMONES    
       

Extra-renal production of 1,25(OH)₂Dз and 24,25(OH)₂Dз in anephric patients [PDF]

1209

 

 

C Graziani, S Adami, S Casati, A Cantaluppi, D Tartarotti, C Castelnovo,
V Lo Cascio, C Ponticelli

 

 

       

Determinants of serum calcium after renal transplantation: the role of 1,25(OH)₂Dз [PDF]

1212

 

 

P A Lucas, R C Brown, L Bloodworth, J S Woodheart, G A Coles

 

 

       

Plasma bone-Gla Protein: assessment of its clinical value as an index of bone
turnover and bone formation in haemodialysis patients
[PDF]

1218

 

 

J L Sebert, J C Ruiz, J Gueris, P Fardellone, A Marie, Ph Moriniere, G Lambrey,
A Smadja, A Fournier

 

 

       

Short and long term effects of 1,25(OH)₂Dз on serum concentrations of
bone-GLA protein in pre-dialysis chronic renal failure [PDF]

1223

 

 

G Coen, S Mazzaferro, G Donato, F Bondatti, A Landi, C Massimetti, A Smacchi, G A Cinotti

 

 

       

Control of hyperphosphataemia by oral magnesium carbonate on zero magnesium
dialysate without aluminium binders
[PDF]

1229

 

 

R O'Donovan, C Monitz, D Baldwin, J Brewer, M Hammer, M Rogerson, V Parsons

 

 

       

Use of diphosphonates in post-transplant hypercalcaemia [PDF]

1233

 

 

N A T Hamdy, R E S Gray, C B Brown, A T Raftery, A D Paterson, J A Kanis

 

 

     

 

Subject Index [PDF]

1239

 

 

 

 

 

Author Index [PDF]

1253

 

     

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

In order to open the above PDF files you need Acrobat Reader.

If you do not have it, you can download it here